Next Biomedical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	321,986	733,427	331,554	-	-	-
Market Cap Growth	0.66%	121.21%	-	-	-	-
Enterprise Value	295,808	714,251	316,300	-	-	-
Last Close Price	38900.00	89400.00	41000.00	-	-	-
PE Ratio	-	-	115.95	-	-	-
PS Ratio	19.14	44.51	34.74	-	-	-
PB Ratio	6.58	15.25	7.34	-	-	-
P/TBV Ratio	6.62	15.35	7.39	-	-	-
P/OCF Ratio	898.90	586.68	-	-	-	-
EV/Sales Ratio	17.58	43.35	33.15	-	-	-
Debt / Equity Ratio	0.15	0.16	0.24	0.70	0.56	6.25
Net Debt / Equity Ratio	-0.53	-0.61	-0.68	-0.17	-0.19	1.92
Net Debt / EBITDA Ratio	36.79	145.67	9.95	0.58	0.71	-1.49
Net Debt / FCF Ratio	9.65	15.40	18.70	0.66	0.45	-1.60
Asset Turnover	0.28	0.28	0.22	0.16	0.08	0.07
Inventory Turnover	1.85	1.79	1.60	1.37	1.61	1.83
Quick Ratio	4.59	4.89	3.68	1.35	1.38	1.70
Current Ratio	5.11	5.38	3.95	1.57	1.59	1.82
Return on Equity (ROE)	-0.08%	-0.67%	9.28%	-41.64%	-46.30%	-
Return on Assets (ROA)	-1.31%	-0.76%	-5.05%	-10.57%	-10.03%	-13.55%
Return on Capital Employed (ROCE)	-2.40%	-1.40%	-7.60%	-28.70%	-27.30%	-26.10%
Earnings Yield	-0.01%	-0.04%	0.86%	-	-	-
FCF Yield	-0.84%	-0.26%	-0.50%	-	-	-
Buyback Yield / Dilution	-6.44%	-12.84%	-14.72%	-1.10%	-28.34%	-13.05%